A new study, led by researchers at the CAMS Oxford Institute in the Nuffield Department of Medicine and TIDU in the MRC Weatherall Institute of Molecular Medicine, has found that specific T cells could have an impact on the long-term protective responses to future infection.
Oxford University Clinical Research Unit (OUCRU) announced promising results from the VIETNARMS trial, a years-long multi-arm clinical trial conducted in Vietnam. The trial found that the readily available and affordable Hepatitis C treatment sofosbuvir/daclatasvir had a >95% cure rate. The results offer important insights into new treatment regimens for Hepatitis C, potentially reducing treatment durations and halving treatment costs.
Green Templeton College recently hosted a powerful event, building on the Nuffield Department of Primary Care Health Sciences 12-part 'Decolonising Global Health' blog series. The event brought together voices from the Global South to share their experiences, challenge entrenched power dynamics and explore practical strategies for creating more equitable health systems.
The MBRRACE-UK collaboration, jointly led by Oxford Population Health\u2019s National Perinatal Epidemiology Unit and the University of Leicester\u2019s TIMMS research group, has today published a \u2018State of the Nation\u2019 report on perinatal deaths of babies born in the UK in 2023.
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
A pioneering clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson\u2019s has recruited its first UK participant from the Discovery Cohort study at the Oxford Parkinson\u2019s Disease Centre (OPDC)
Professor Sir Aziz Sheikh OBE gave his inaugural lecture at the University of Oxford, sharing his vision for transforming global health care through data, innovation and equity.
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues\u2014addressing a major challenge in current immunotherapy.
Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).
Researchers at Oxford Population Health studying genetic variants that control levels of Lipoprotein(a), or Lp(a) discovered that lowering Lp(a) could reduce the risk of heart attack and large artery stroke in both East Asians and Europeans. The study is published in Circulation.
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Professor Ole Jensen is part of a global consortium that embraced a novel collaborative approach to investigating one of the brain\u2019s greatest mysteries
A collaborative study between the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division at the University of Oxford has been awarded the 2024 PNAS Cozzarelli Prize in Biomedical Science.
A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden.
Research published in the journal Human Reproduction reveals that women with endometriosis are at a significantly higher risk for developing a range of autoimmune, autoinflammatory, and mixed-pattern diseases.
On the 25 and 26 April the MSc in International Health and Tropical Medicine, IHTM, celebrated its tenth anniversary as an internationally renowned programme for future global health leaders, with over 100 alumni travelling from around the world to join colleagues, current students and guests in Oxford.
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.
![\"Female](\"https://www.medsci.ox.ac.uk/news/t-cell-responses-to-monkeypox-virus-play-a-part-in-protecting-against-infection/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n